China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

The "most promising areas" are integrated device manufacturers (IDMs) and high-end outsourced assembly and test (OSAT) ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

Precision medicine is an innovative approach in healthcare that takes into account individual differences in genes, ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

Ancient DNA is telling us more and more about humans and environments long past. Could it also help rescue the future?

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a ...

Through new partnerships with industry leaders, Nvidia aims to help advance practical use cases for AI in healthcare and life ...